Europa Trial
Home
Sitemap
General Public Heathcare Professionals Virtual Press Office

New Indication in CAD

EUROPA calendar
ACC 2006 - Posters
ESC 2005 - Symposium
ESC 2005 - Oral sessions
ESC 2005 - Posters
AHA 2004 - Oral Session
ESC 2004 - Hotline
ESC 2004 - Symposium
ACC 2004
ESC 2003


EUROPA study
EUROPA Results
ESC 2003 Hotline - video
Rationale for EUROPA
Rationale for Perindopril
Design & Organisation
EUROPA investigators
EUROPA collaborating centres
EUROPA Recruitment


EUROPA Slide Set
Rationale and Design
Results
Clinical Implications


EUROPA publications


PERSUADE
PERSUADE Publications
PERSUADE Results
PERSUADE Fact Sheet


PERTINENT
PERTINENT Results
PERTINENT Fact Sheet


Background : Coronary Artery Disease
Home : Healthcare professionals : ACC 2006 - Posters
ACC 2006 - Posters




Tuesday, March 14, 2006
Georgia World Congress Center, Hall B1

Poster Session: Cardiac Risk and Risk Reduction (8:30 AM -12:00 PM)


Ref 1014-211

Risk Assessment and Risk Reduction by Perindopril in Patients With Normal Left Ventricular Function or Previous Revascularization in the EUROPA Study

Prof Willem J. Remme Click here




Tuesday, March 14, 2006
Georgia World Congress Center, Hall B1

Poster Session: Medical Therapy (8:30 AM -12:00 PM)


Ref 999-251

Effects of Perindopril on Cardiac Events in Revascularized Coronary Artery Disease Patients

Prof Maarten L. Simoons Click here


Ref 999-257

Effects of Perindopril on Long-Term Clinical Outcome of Patients With Coronary Artery Disease and Left Ventricular Function

Prof Michel E. Bertrand Click here




This website is intended for an international audience. Drug related information may refer to unlicensed products or uses which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the EUROPA study investigators. Site last updated March 21st 2006
To report a suspected side-effect with a Servier drug, please click here.
Terms of use - ©2005 EUROPA All rights reserved